Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-145.24%
operating margin TTM
-158.21%
revenue TTM
7.10 Billion
revenue per share TTM
17.98$
valuation ratios | |
|---|---|
| pe ratio | -7.52 |
| peg ratio | -0.76 |
| price to book ratio | 2.45 |
| price to sales ratio | 11.00 |
| enterprise value multiple | -8.64 |
| price fair value | 2.45 |
profitability ratios | |
|---|---|
| gross profit margin | 14.1% |
| operating profit margin | -158.21% |
| pretax profit margin | -142.46% |
| net profit margin | -145.24% |
| return on assets | -22.87% |
| return on equity | -30.15% |
| return on capital employed | -29.7% |
liquidity ratios | |
|---|---|
| current ratio | 3.29 |
| quick ratio | 3.22 |
| cash ratio | 1.31 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 33.46 |
| operating cycle | 68.03 |
| days of payables outstanding | 69.33 |
| cash conversion cycle | -1.30 |
| receivables turnover | 10.56 |
| payables turnover | 5.26 |
| inventory turnover | 10.91 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.16 |
| debt equity ratio | 0.22 |
| long term debt to capitalization | 0.13 |
| total debt to capitalization | 0.18 |
| interest coverage | -1,537.00 |
| cash flow to debt ratio | -0.97 |
cash flow ratios | |
|---|---|
| free cash flow per share | -5.24 |
| cash per share | 14.79 |
| operating cash flow per share | -4.72 |
| free cash flow operating cash flow ratio | 1.11 |
| cash flow coverage ratios | -0.97 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -9.17 |
Frequently Asked Questions
When was the last time Moderna, Inc. (NASDAQ:MRNA) reported earnings?
Moderna, Inc. (MRNA) published its most recent earnings results on 06-11-2025.
What is Moderna, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Moderna, Inc. (NASDAQ:MRNA)'s trailing twelve months ROE is -30.15%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Moderna, Inc. (MRNA) currently has a ROA of -22.87%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MRNA's net profit margin stand at?
MRNA reported a profit margin of -145.24% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MRNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.29 in the most recent quarter. The quick ratio stood at 3.22, with a Debt/Eq ratio of 0.22.